Get the Stockscreener App
5.10
1.59%
0.08
After Hours:
5.20
0.10
+1.96%
Imunon Inc stock is traded at $5.10, with a volume of 168.18K.
It is up +1.59% in the last 24 hours and down -11.30% over the past month.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
See More
Previous Close:
$5.02
Open:
$5.02
24h Volume:
168.18K
Relative Volume:
0.77
Market Cap:
$12.44M
Revenue:
$500.00K
Net Income/Loss:
$-19.45M
P/E Ratio:
-2.6984
EPS:
-1.89
Net Cash Flow:
$-18.22M
1W Performance:
-4.32%
1M Performance:
-11.30%
6M Performance:
-55.06%
1Y Performance:
-62.04%
1-Day Range:
$4.995
$5.15
1-Week Range:
$4.9105
$5.40
52-Week Range:
$4.70
$41.22
Imunon Inc Stock (IMNN) Company Profile
Name
Imunon Inc
Sector
Industry
Phone
(609) 896-9100
Address
997 LENOX DRIVE, LAWRENCEVILLE
Compare IMNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMNN
Imunon Inc
|
5.10 | 12.66M | 500.00K | -19.45M | -18.22M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Imunon Inc Stock (IMNN) Latest News
Analyzing recovery setups for Imunon Inc. investorsPortfolio Return Summary & Real-Time Buy Signal Notifications - newser.com
Imunon Inc. stock daily chart insightsPortfolio Update Summary & Stepwise Entry and Exit Trade Signals - newser.com
Can Imunon Inc. (CBO) stock surprise markets with earningsWeekly Gains Report & AI Powered Market Trend Analysis - newser.com
Imunon to present Phase 3 OVATION trial of IMNN-001 - TipRanks
IMNN Advances in Ovarian Cancer Treatment with IMNN-001 - GuruFocus
IMUNON, Inc. Announces Phase 3 OVATION 3 Trial of DNA-Mediated Immunotherapy to be Presented at ESMO Congress 2025 - Quiver Quantitative
IMUNON begins Phase 3 trial of ovarian cancer immunotherapy - Investing.com
IMUNON to Present Phase 3 Ovarian Cancer Study of IMNN-001 at ESMO Congress - Yahoo Finance
Risk vs reward if holding onto Imunon Inc.Weekly Loss Report & Reliable Entry Point Trade Alerts - newser.com
Identifying reversal signals in Imunon Inc.Bull Run & Technical Confirmation Trade Alerts - newser.com
Is Imunon Inc. stock ready for a breakoutJuly 2025 Breakouts & Fast Gain Swing Alerts - newser.com
Is Imunon Inc. stock cheap at current valuationPrice Action & Risk Controlled Daily Trade Plans - newser.com
What margin trends mean for Imunon Inc. stockJuly 2025 Analyst Calls & Free Accurate Trade Setup Notifications - newser.com
Will Imunon Inc. price bounce be sustainableJuly 2025 Rallies & Real-Time Volume Spike Alerts - newser.com
Risk adjusted return profile for Imunon Inc. analyzedJuly 2025 Closing Moves & Stepwise Entry/Exit Trade Alerts - newser.com
Volume spikes in Imunon Inc. stock – what they meanQuarterly Earnings Report & High Conviction Buy Zone Alerts - newser.com
Chart based analysis of Imunon Inc. trends2025 Sector Review & Accurate Entry/Exit Alerts - newser.com
What market sentiment indicators show for Imunon Inc. (CBO) stockJuly 2025 Snapshot & Safe Capital Investment Plans - newser.com
Will Imunon Inc. (CBO) stock attract long term capital inflows2025 Growth vs Value & High Accuracy Buy Signal Tips - newser.com
What Fibonacci levels say about Imunon Inc. reboundChart Signals & Verified Short-Term Plans - newser.com
Long term hold vs stop loss in Imunon Inc.July 2025 Highlights & Expert Approved Momentum Ideas - newser.com
How Imunon Inc. stock responds to policy changesJuly 2025 Selloffs & AI Driven Price Predictions - newser.com
News impact scoring models applied to Imunon Inc.July 2025 Drop Watch & Reliable Price Breakout Alerts - newser.com
Applying Wyckoff theory to Imunon Inc. stock2025 Valuation Update & AI Powered Market Trend Analysis - newser.com
Why Imunon Inc. stock attracts high net worth investorsEarnings Overview Summary & Expert Approved Momentum Ideas - newser.com
How to manage a losing position in Imunon Inc.Analyst Upgrade & Daily Profit Focused Stock Screening - newser.com
Real time alert setup for Imunon Inc. performanceJuly 2025 Volume & Smart Investment Allocation Insights - newser.com
What earnings revisions data tells us about Imunon Inc.July 2025 Pullbacks & Short-Term Swing Trade Alerts - newser.com
Imunon Inc Stock (IMNN) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):